western-biopharma-firms-trying-to-catch-the-chinese-dragon-by-its-tail

It's raining expansions and JVs in China!

  • China
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Biopharma firms, which are located on the western part of the globe, are keeping a close watch on the dragon nation, with hopes that they can leverage on the potential... Read more

mr-ken-c-lai-the-new-vp-of-lanzatech-s-asia-pacific-operations

Lai to head LanzaTech China operations

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: LanzaTech appointed Mr Ken C Lai as VP of its Asia Pacific operations. Based in Shanghai, he will oversee the development and commercialization of the... Read more

trouble-free-logistic-support-dhl-expands-its-qualified-envirotainer-provider-qep-accreditation-to-30-stations-worldwide

DHL expands secure cold chain network

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: DHL Global Forwarding, the air and ocean freight specialist, has expanded its Qualified Envirotainer Provider (QEP) Accreditation to 30 stations in locations... Read more

good-news-for-rheumatic-disorder-patients-cipla-launches-the-first-biosimilar-of-etanercept-in-india-under-the-brand-name-etacept

Cipla launches first rheumatic drug biosimilar in India...

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Mumbai: Cipla launched the first biosimilar of Etanercept in India under the brand name, Etacept, indicated for the treatment of rheumatic disorders. Etacept is... Read more

chipscreen-gets-sfda-nod-after-accelerated-review

Chipscreen gets SFDA nod after accelerated review

  • China
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

‎Singapore: China-based Chipscreen Biosciences announced the achievement of the primary endpoint in the pivotal, registrational phase II Chipel trial of Chidamide... Read more

global-information-gii-research-estimates-the-chinese-medical-device-market-to-surpass-usd96

China to surpass Japan as 2nd largest medtech market

  • China
  • |
  • Analysis
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: As the world's largest population, prospects for medical device spending in China is huge. Government healthcare reforms are a major driving force behind... Read more

origene-to-acquire-sdix-life-science-assets

OriGene to acquire SDIX life science assets

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: OriGene Technologies, genome wide product company for research and diagnostic applications, acquired all the assets of life science business of SDIX,... Read more

as-of-april-12-china-bird-flu-has-killed-10-and-infected-38

H7N9 China bird flu update: 38 infected, 10 dead

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The National Health and Family Planning Commission of China has notified WHO of an additional 10 laboratory-confirmed cases of human infection with influenza... Read more

craig-venter-institute-synthetic-genomics-vaccines-and-novartis-will-synthesize-bird-flu-h7n9-genes-following-a-request-from-the-us-cdc

Venter lab, Novartis to synthesize new bird flu genes

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The J Craig Venter Institute (JCVI) and Synthetic Genomics Vaccines (SGVI), US, are working with Novartis to synthesize the genes of the new viral strain... Read more

Special Features

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X